David Andrae

Title: David Andrae: Innovator in Opioid Receptor Modulation

Introduction

David Andrae is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of opioid receptor modulators. His work focuses on creating abuse-deterrent solid dosage formulations that aim to improve patient safety and efficacy.

Latest Patents

David holds a patent for "Opioid receptor modulator dosage formulations." This patent includes abuse-deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, along with processes for the preparation and administration of these formulations. This innovation is crucial in addressing the ongoing opioid crisis by providing safer medication options.

Career Highlights

David Andrae is currently associated with Allergan Holdings Unlimited Company, where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in dosage formulations has positioned him as a key player in the field.

Collaborations

Some of David's coworkers include Tim Costello and Leonard Scott Dove. Their collaborative efforts contribute to the advancement of research and development in opioid receptor modulation.

Conclusion

David Andrae's work in opioid receptor modulation exemplifies the importance of innovation in the pharmaceutical industry. His contributions are vital in creating safer medication options for patients.